Wang Junyuan Jerry

CIK 2017749 · CEO, ANHEART THERAPEUTICS LTD. · last filed 2024-11-13

Wang Junyuan Jerry is a CEO, ANHEART THERAPEUTICS LTD. who has filed 3 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing shows the insider sold $162.9K of NUVB.WS on Nov 13, 2024. Across all open-market trades the lifetime net is −$162.9K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

3

Lifetime Open-Market Net

-$162.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NUVB.WS CEO, ANHEART THERAPEUTICS LTD. 6,112,686 $0.01 -$162.9K 3 2024-11-13

Recent Filings

3 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-11-13 NUVB.WS Sell (S) −56,361 -$162.9K EDGAR
2024-09-05 NUVB.WS Mixed +4,239,300 $0 EDGAR
2024-04-11 NUVB.WS Grant (A) +1,929,747 $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.